About Zhi Hong, Ph.D.
Form D filings for RenBio in 2024 list Zhi Hong, Ph.D. as director.
Zhi Hong, Ph.D. first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Zhi Hong, Ph.D. in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Zhi Hong, Ph.D. works with at each company, as listed on that company's latest Form D.
RenBio, Inc. · Form D, Sep 6, 2024
JD
Jaap Goudsmit, M.D., Ph.D.
Director
RD
Rachel Liberatore, Ph.D.
President and Chief Scientific Officer, director
DT
Donald Tang
Director
AR
Annelyn O'Rourke
Executive officer
WS
Walter Wang, Sr.
Director